STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 79 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q3 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $155,000 | +93.8% | 56,215 | +71.1% | 0.00% | – |
Q4 2020 | $80,000 | +90.5% | 32,851 | +64.0% | 0.00% | – |
Q3 2020 | $42,000 | -39.1% | 20,036 | +9.4% | 0.00% | – |
Q2 2020 | $69,000 | +228.6% | 18,313 | +62.6% | 0.00% | – |
Q1 2020 | $21,000 | -69.6% | 11,263 | -66.4% | 0.00% | – |
Q4 2019 | $69,000 | +228.6% | 33,513 | +268.2% | 0.00% | – |
Q3 2019 | $21,000 | -88.5% | 9,102 | -84.5% | 0.00% | – |
Q2 2019 | $182,000 | +1922.2% | 58,656 | +2917.3% | 0.00% | – |
Q1 2019 | $9,000 | -98.3% | 1,944 | -98.3% | 0.00% | – |
Q4 2018 | $518,000 | -56.0% | 115,700 | -52.3% | 0.00% | – |
Q3 2018 | $1,176,000 | -21.6% | 242,510 | -3.0% | 0.00% | – |
Q2 2018 | $1,500,000 | +164.1% | 250,074 | +288.3% | 0.00% | – |
Q1 2018 | $568,000 | +40.9% | 64,409 | +15.6% | 0.00% | – |
Q4 2017 | $403,000 | +203.0% | 55,711 | +185.0% | 0.00% | – |
Q3 2017 | $133,000 | -25.3% | 19,551 | -22.3% | 0.00% | – |
Q2 2017 | $178,000 | +5833.3% | 25,157 | +1472.3% | 0.00% | – |
Q4 2016 | $3,000 | – | 1,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 5,376,039 | $47,309,000 | 51.34% |
Lyon Street Capital, LLC | 3,182,149 | $28,162,000 | 9.07% |
Opaleye Management Inc. | 1,590,000 | $14,071,000 | 4.02% |
Broadfin Capital, LLC | 2,793,752 | $24,725,000 | 3.85% |
Vivo Capital, LLC | 1,918,132 | $16,975,000 | 2.40% |
ARMISTICE CAPITAL, LLC | 3,372,000 | $29,842,000 | 2.28% |
PRECEPT MANAGEMENT LLC | 470,000 | $4,160,000 | 1.73% |
NEA Management Company, LLC | 4,141,308 | $36,651,000 | 1.63% |
Harvest Capital Strategies LLC | 825,000 | $7,301,000 | 1.14% |
Granite Point Capital Management, L.P. | 567,895 | $5,026,000 | 0.49% |